Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis

References

• Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. J. Hepatol. 75(1), S101–S117 (2021).
   PubMedGoogle Scholar
• Dionigi E, Garcovich M, Borzio M et al. Bacterial infections change natural history of cirrhosis irrespective of liver disease severity. Am. J. Gastroenterol. 112(4), 588–596 (2017).
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. N. Engl. J. Med. 384(24), 2317–2330 (2021).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global action plan on antimicrobial resistance (2015). https://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_R7-en.pdf
   Google Scholar
• Martínez J, Hernández-Gea V, Rodríguez-de-Santiago E et al. Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis. J. Hepatol. 75(2), 342–350 (2021).
   PubMed Web of Science ®Google Scholar
• Van der Merwe S, Chokshi S, Bernsmeier C, Albillos A. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J. Hepatol. 75(1), S82–S100 (2021).
   PubMedGoogle Scholar
• Piano S, Singh V, Caraceni P et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 156(5), 1368–1380 (2019).
   PubMed Web of Science ®Google Scholar
• Cannon MD, Martin P, Carrion AF. Bacterial infection in patients with cirrhosis: don't get bugged to death. Dig. Dis. Sci. 65(1), 31–37 (2020).
   PubMed Web of Science ®Google Scholar
• Marciano S, Valverde M, Dirchwolf M, Gutierrez-Acevedo MN, Gadano A. The Importance of knowing the local epidemiology when a patient with cirrhosis acquires a bacterial infection. Clin Liver Dis. 16(3), 87–90 (2020).
   Google Scholar
• Arroyo V, Angeli P, Moreau R et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J. Hepatol. 74(3), 670–685 (2021).
   PubMed Web of Science ®Google Scholar
• Fernández J, Prado V, Trebicka J et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J. Hepatol. 70(3), 398–411 (2019).
   PubMed Web of Science ®Google Scholar
• Zhao H, Shi Y, Dong H et al. Community- or healthcare-associated bacterial infections increase long-term mortality in patients with acute decompensation of cirrhosis. Am. J. Med. Sci. 355(2), 132–139 (2018).
   PubMed Web of Science ®Google Scholar
• Angeli P, Bernardi M, Villanueva C et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 69(2), 406–460 (2018).
   PubMed Web of Science ®Google Scholar
• Fernández J, Acevedo J, Wiest R et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut 67(10), 1870–1880 (2018).
   PubMed Web of Science ®Google Scholar
• Mücke MM, Rumyantseva T, Mücke VT et al. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality. Liver Int. 38(4), 645–653 (2018).
   PubMed Web of Science ®Google Scholar
• Fernández J, Acevedo J, Prado V et al. Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis. Liver Int. 37(3), 385–395 (2017).
   PubMed Web of Science ®Google Scholar
• Bennett JE, Dolin R, Blaser MJ. In: Mandell, Douglas, and Bennett's infectious disease essentials. Elsevier, PA, USA (2017).
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 18(3), 268–281 (2012).
   PubMed Web of Science ®Google Scholar
• Piano S, Bartoletti M, Tonon M et al. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut 67(10), 1892–1899 (2018).
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801 (2016).
   PubMed Web of Science ®Google Scholar
• Moreau R, Jalan R, Gines P et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144(7), 1426–1437 (2013).
   PubMed Web of Science ®Google Scholar
• Salerno F, Borzio M, Pedicino C et al. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study. Liver Int. 37(1), 71–79 (2017).
   PubMed Web of Science ®Google Scholar
• Zhao R, Ma J, Li P et al. Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study. Expert Rev. Gastroenterol. Hepatol. 12(11), 1167–1174 (2018).
   PubMed Web of Science ®Google Scholar
• Tang D, Maihebuba B, Sun XF, Lu XB. [Analysis of pathogenic bacteria in cirrhotic patients complicated with bacterial infection in a tertiary hospital in Xinjiang]. Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi Chin. J. Hepatol. 30(8), 885–888 (2022).
   Google Scholar
• Allaire M, Cadranel JF, Nguyen TTN et al. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: a systematic review. Clin. Res. Hepatol. Gastroenterol. 44(3), 264–274 (2020).
   PubMed Web of Science ®Google Scholar
• Hillert A, Schultalbers M, Tergast TL et al. Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany. BMC Gastroenterol. 21(1), 296 (2021).
   PubMed Web of Science ®Google Scholar
• Fernández J, Acevedo J, Castro M et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 55(5), 1551–1561 (2012).
   PubMed Web of Science ®Google Scholar
• Bajaj JS, O'Leary JG, Reddy KR et al. Second Infections Independently Increase Mortality in Hospitalized Cirrhotic Patients: The NACSELD Experience. Hepatol. Baltim. Md. 56(6), 2328–2335 (2012).
   PubMed Web of Science ®Google Scholar
• Moreau R, Elkrief L, Bureau C et al. Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis. Gastroenterology 155(6), 1816–1827 (2018).
   PubMed Web of Science ®Google Scholar
• Gupta T, Lochan D, Verma N et al. Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission. J. Gastroenterol. Hepatol. 35(3), 461–466 (2020).
   PubMed Web of Science ®Google Scholar
• Wong F, Piano S, Singh V et al. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. J. Hepatol. 74(2), 330–339 (2021).
   PubMed Web of Science ®Google Scholar
• Kremer WM, Gairing SJ, Kaps L et al. Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany. Ann Hepatol. 27(5), 100719 (2022).
   PubMed Web of Science ®Google Scholar
• Dalbeni A, Mantovani A, Zoncapè M et al. The multidrug-resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: an Italian cohort study. PLOS ONE. 18(2), 281813 (2023).
   Web of Science ®Google Scholar
• Pouriki S, Alexopoulos T, Vasilieva L, Vrioni G, Alexopoulou A. Rectal colonization by resistant bacteria is associated with infection by the colonizing strain and high mortality in decompensated cirrhosis. J. Hepatol. 77(4), 1207–1208 (2022).
   PubMed Web of Science ®Google Scholar
• Richter SS, Marchaim D. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How? Virulence. 8(4), 417–426 (2017).
   PubMed Web of Science ®Google Scholar